Ad is loading...
RWICX
Price
$66.66
Change
-$0.71 (-1.05%)
Updated
Nov 15 closing price
WGIFX
Price
$67.14
Change
-$0.71 (-1.05%)
Updated
Nov 15 closing price
Ad is loading...

RWICX vs WGIFX

Header iconRWICX vs WGIFX Comparison
Open Charts RWICX vs WGIFXBanner chart's image
American Funds Capital World Gr&Inc R3
Price$66.66
Change-$0.71 (-1.05%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc F2
Price$67.14
Change-$0.71 (-1.05%)
VolumeN/A
CapitalizationN/A
RWICX vs WGIFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWICX vs. WGIFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWICX is a Sell and WGIFX is a Sell.

FUNDAMENTALS
Fundamentals
RWICX (125B) and WGIFX (125B) have equal amount of cash in the bank . WGIFX pays higher dividends than RWICX: WGIFX (1.90) vs RWICX (1.43). RWICX was incepted earlier than WGIFX: RWICX (22 years) vs WGIFX (16 years). RWICX (27.00) and WGIFX (27.00) have comparable annual turnover. RWICX (250) and WGIFX (250) have matching initial minimum investment requirements. WGIFX (19.40) and RWICX (18.74) have marching annual gain over last year. WGIFX return over 5 years is better than : 39.76 vs. RWICX (37.64).
RWICXWGIFXRWICX / WGIFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years16 years-
Gain YTD12.80513.34196%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets125B125B100%
Annual Yield % from dividends1.431.9075%
Returns for 1 year18.7419.4097%
Returns for 3 years2.583.7269%
Returns for 5 years37.6439.7695%
Returns for 10 years47.9850.5895%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USNA40.340.90
+2.28%
USANA Health Sciences
CXT55.490.20
+0.36%
Crane NXT Co
SVRE1.29-0.02
-1.80%
SaverOne 2014 Ltd
ILMN135.05-7.19
-5.05%
Illumina
ACRV6.96-0.96
-12.12%
Acrivon Therapeutics